Evidence map›Paper›PMID 36127525›Full record

ArticleArchives of gynecology and obstetrics2023

Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database.

M Bossart, H Plett, B Krämer, E Braicu, B Czogalla, M Klar, S Singer, D Mayr, A Staebler, A du Bois and 10 more

Open access · hybridFull text readMulticenter Study
In one paragraph

Article in Archives of gynecology and obstetrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 1 country.

M BossartDepartment of Gynecology and Obstetrics, University Medical Center Freiburg, Freiburg im Breisgau, Germany. Michaela.Bossart@rkk-klinikum.de.ORCID http://orcid.org/0000-0003-3218-912X
H PlettDepartment of Gynecology & Gynecologic Oncology, Ev. Kliniken Essen-Mitte (KEM), Essen, Germany.
B KrämerDepartment of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
E BraicuDepartment of Gynecology, Charité Berlin, Campus Virchow Clinic, Berlin, Germany.
B CzogallaDepartment of Obstetrics and Gynecology, University Hospital, Ludwig- Maximilians- University Munich, Munich, Germany.
M KlarDepartment of Gynecology and Obstetrics, University Medical Center Freiburg, Freiburg im Breisgau, Germany.
S SingerInstitute of Medical Biostatistics, Epidemiology and Informatics, Division of Epidemiology and Health Care Research, University Medical Center Mainz, Mainz, Germany.
D MayrInstitut of Pathology, Ludwig-Maximilians- University Munich, Munich, Germany.
A StaeblerDivision of Gynecologic Pathology, Institute of Pathology and Neuropathology, University of Tuebingen, Tuebingen, Germany.
A du BoisDepartment of Gynecology & Gynecologic Oncology, Ev. Kliniken Essen-Mitte (KEM), Essen, Germany.
S KommossDepartment of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
T LinkDepartment of Gynecology and Obstetrics, Technische Universität Dresden Dresden and National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.
A BurgesDepartment of Obstetrics and Gynecology, University Hospital, Ludwig- Maximilians- University Munich, Munich, Germany.
F HeitzDepartment of Gynecology & Gynecologic Oncology, Ev. Kliniken Essen-Mitte (KEM), Essen, Germany.
M GrubeDepartment of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
F TrillschDepartment of Obstetrics and Gynecology, University Hospital, Ludwig- Maximilians- University Munich, Munich, Germany.
P HarterDepartment of Gynecology & Gynecologic Oncology, Ev. Kliniken Essen-Mitte (KEM), Essen, Germany.
P WimbergerDepartment of Gynecology and Obstetrics, Technische Universität Dresden Dresden and National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.
P BuderathDepartment of Gynecology and Obstetrics, University Hospital Essen, Essen, Germany.
A HasenburgDepartment of Gynecology and Obstetrics, University Medical Center Mainz, Mainz, Germany.
Kliniken Essen-Mitte · DELudwig-Maximilians-Universität München · DEJohannes Gutenberg University Mainz · DENational Center for Tumor Diseases · DEUniversity Medical Center Freiburg · DECharité - Universitätsmedizin Berlin · DEEssen University Hospital · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe intention of this study was to evaluate the level of anxiety and depression of malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST) survivors and to identify possible alterable cofactors.

methodsCORSETT was an observational, multicenter, mixed retrospective/prospective cohort study of the AGO Studygroup. Women who had been diagnosed with MOGCTs and SCSTs between 2001 and 2011 were asked to complete the Hospital Anxiety and Depression Scale (HADS) to evaluate distress. Predictors of distress (type of surgery, chemotherapy, time since diagnosis, recurrence, second tumor, pain) were investigated using multivariate linear regression analysis.

results150 MOGCT and SCST patients with confirmed histological diagnosis completed the questionnaire median seven years after diagnosis. They had a HADS total score ≥ 13 indicating severe mental distress in 34% of cases. Patients after fertility-conserving surgery had lower probability of severe mental distress than those without fertility-conserving treatment (β = - 3.1, p = 0.04). Pain was associated with the level of distress in uni- and multivariate analysis (coef 0.1, p < 0.01, coef. Beta 0.5). DISCUSSION: Severe mental distress was frequent in patients with MOGCT and SCST and the level of pain was associated with the level of distress. Fertility conserving therapy, however, was associated with less mental distress. Screening and treatment of pain and depression is required to improve mental well-being in survivors of MOGCT and SCST.

Indexed as

Neoplasms, Germ Cell and EmbryonalOvarian NeoplasmsSex Cord-Gonadal Stromal TumorsAnxietyFemaleGerm CellsHumansPainProspective StudiesRetrospective StudiesAnxietyDepressionFertility-sparing surgeryOvarian germ cell tumorsPainSex cord stromal tumors

Identifiers

PMID36127525
PMCPMC10023613
OpenAlexW4296964194

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read119
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.